KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Gross Margin (2016 - 2025)

Globus Medical (GMED) has disclosed Gross Margin for 15 consecutive years, with 68.41% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 848.0% year-over-year to 68.41%, compared with a TTM value of 67.41% through Dec 2025, up 851.0%, and an annual FY2025 reading of 67.41%, up 851.0% over the prior year.
  • Gross Margin was 68.41% for Q4 2025 at Globus Medical, up from 67.16% in the prior quarter.
  • Across five years, Gross Margin topped out at 75.8% in Q1 2021 and bottomed at 56.77% in Q3 2024.
  • Average Gross Margin over 5 years is 68.6%, with a median of 71.09% recorded in 2023.
  • The sharpest move saw Gross Margin plummeted -1734bps in 2023, then soared 1040bps in 2025.
  • Year by year, Gross Margin stood at 75.28% in 2021, then decreased by -1bps to 74.28% in 2022, then dropped by -23bps to 56.94% in 2023, then grew by 5bps to 59.92% in 2024, then rose by 14bps to 68.41% in 2025.
  • Business Quant data shows Gross Margin for GMED at 68.41% in Q4 2025, 67.16% in Q3 2025, and 66.62% in Q2 2025.